Full Picture

Article analysis:

This article provides a comprehensive overview of the impact of SARS and COVID-19 on China's stock market. The author has used an event study approach to test the impact of emergencies such as SARS and COVID-19, as well as a time series analysis to investigate the relationship between COVID-19, the stock market, oil prices, and economic policy uncertainty. The article is well written with clear arguments supported by evidence from reliable sources such as World Health Organization (WHO). However, there are some potential biases that should be noted. For example, while the author has discussed both SARS and COVID-19 in detail, they have not explored any counterarguments or alternative perspectives on their effects on China's stock market. Additionally, while they have provided evidence for their claims from reliable sources such as WHO data, they have not presented any evidence from other sources which could provide further insight into this topic. Furthermore, while they have discussed some potential risks associated with these epidemics in terms of their impacts on China's stock market performance, they have not provided any detailed information about how these risks can be mitigated or managed in order to minimize their effects. Finally, while they have discussed both epidemics in detail from a Chinese perspective only limited attention has been given to how these epidemics may affect other countries' stock markets around the world.